Clinical Trials Logo

Communicable Diseases clinical trials

View clinical trials related to Communicable Diseases.

Filter by:

NCT ID: NCT00999622 Completed - Infection Clinical Trials

Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma

Start date: July 2004
Phase: N/A
Study type: Observational

RATIONALE: Gathering information over time from laboratory tests of patients with newly diagnosed malignant supratentorial astrocytoma may help doctors learn more about the effect of treatment on white blood cell count and the risk of infection. PURPOSE: This clinical trial is studying blood samples and risk of infection in patients with newly diagnosed malignant supratentorial astrocytoma.

NCT ID: NCT00991289 Completed - HIV Infection Clinical Trials

Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects

Start date: January 2010
Phase: Phase 2
Study type: Interventional

Infection with hepatitis C virus (HCV) can cause liver scarring, or cirrhosis, and this usually occurs more rapidly among people infected with both HCV and human immunodeficiency virus (HIV). People infected with both HCV and HIV have poor response to the current HCV treatments. This phase II pilot study evaluated whether adding a new HCV medication improves response to the current standard HCV treatment with pegylated interferon and ribavirin in people with both HCV and HIV.

NCT ID: NCT00990392 Withdrawn - Clinical trials for Skin Diseases, Infectious

Topical Antibiotics for Prevention of Intensive Care Unit (ICU) Central Line Infections

ToPICL
Start date: November 2009
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if the overall central venous catheter related infection rate can be reduced by the application of Polysporin Triple Therapy ointment to the insertion site.

NCT ID: NCT00989144 Completed - HIV Infections Clinical Trials

Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort

SEARCH004
Start date: January 2007
Phase: N/A
Study type: Observational

The study of early, acute HIV infection is critical to understanding subtype-specific pathophysiologic differences, since up to 50% of acute HIV infections may be incapacitating. This study will establish whether the patient population of the Thai Red Cross Anonymous Clinic is suitable for the study of early, acute infection.

NCT ID: NCT00979667 Terminated - Influenza Clinical Trials

A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

Start date: October 2009
Phase: Phase 3
Study type: Interventional

To evaluate the efficacy of oseltamivir ,as compared with the placebo arm and zanamivir with its control arm with respect to symptoms duration among patients infected with influenza A (H1N1) virus.

NCT ID: NCT00978497 Completed - HCV Infection Clinical Trials

Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection

Start date: September 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety, tolerability and effectiveness of ANA598 when administered with pegylated interferon and ribavirin (Standard of Care [SOC]) compared to placebo + SOC.

NCT ID: NCT00975377 Completed - Clinical trials for Surgical Site Infection

Clipping Versus No Hair Removal and the Risk of Surgical Site Infections

Start date: October 2009
Phase: N/A
Study type: Interventional

The objective of this study is to determine whether hair clipping is non-inferior to no hair removal in preventing superficial, deep, and organ space surgical site infections (SSI) in patients undergoing various general surgical procedures, evaluated after surgery by an assessor blinded to treatment allocation. Additional goals include evaluating wound complications that arise in patients that have hair clipped and in patients that do not have hair removed and determining the impact of clipping versus no hair removal and SSI versus no SSI on length of hospital stay.

NCT ID: NCT00974493 Completed - Joint Infection Clinical Trials

Oral Versus Intravenous Antibiotics for Bone and Joint Infections (OVIVA B&J)

OVIVA
Start date: June 2010
Phase: Phase 4
Study type: Interventional

The study will compare the outcomes of treating bone and joint infections with 6 weeks of intravenous antibiotics with 6 weeks of oral antibiotic treatment. The trial is of antibiotic "strategy" rather than of individual antibiotics. The study will be open label, but the primary outcome will be proven failure of infection treatment, determined by pre-established objective criteria for treatment failure. The null hypothesis tested is that there will be no difference in treatment failure rates.

NCT ID: NCT00973583 Completed - Clinical trials for Respiratory Tract Infections

Vitamin D Supplementation for the Prevention of Acute Respiratory Tract Infections

Start date: May 2005
Phase: N/A
Study type: Interventional

The investigators earlier clinical study in 754 young Finnish men demonstrated a significant negative association of serum 25-OHD concentration with acute respiratory tract infections. The present study aimed to determine whether vitamin D supplementation may decrease the incidence of acute respiratory tract infections.

NCT ID: NCT00973466 Completed - HIV Infections Clinical Trials

Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected Patients

CTNG
Start date: May 2009
Phase: N/A
Study type: Observational

There has been an increase in incidence in sexually transmitted infections in HIV infected patients in the last years. In this study the investigators will prospectively evaluate the prevalence of symptomatic and asymptomatic infections with N. gonorrhea and Ch. trachomatis as well as the seroprevalence of Herpes simplex Type 2 infection in HIV-infected patients attending the clinic for infectious diseases at the Berne University Hospital. In addition, participants will be asked to fill out a questionnaire on sexual behaviour and sexual health. Study hypothesis: STI prevalence is high in certain risk-groups to justify screening in regular intervals.